Inventor
BOOKER SHON
US37 patents
⚠️ This page may combine multiple inventors who share the name “BOOKER SHON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
30 patentsUS10640504B2May 5, 2020
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC50 citations97
US10532042B2Jan 14, 2020
KRAS G12C inhibitors and methods of using the same
AMGEN INC49 citations97
US10519146B2Dec 31, 2019
KRAS G12C inhibitors and methods of using the same
AMGEN INC81 citations97
US6878714B2Apr 12, 2005
Substituted alkylamine derivatives and methods of use
AMGEN INC85 citations97
US6995162B2Feb 7, 2006
Substituted alkylamine derivatives and methods of use
AMGEN INC48 citations95
US11306087B2Apr 19, 2022
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC16 citations94
US11096939B2Aug 24, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC24 citations94
US11090304B2Aug 17, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC33 citations94
US11285135B2Mar 29, 2022
KRAS G12C inhibitors and methods of using the same
AMGEN INC20 citations93
US7858623B2Dec 28, 2010
Substituted amide derivatives and methods of use
AMGEN INC15 citations93
US7435823B2Oct 14, 2008
Compounds and methods of use
AMGEN INC19 citations92
US7102009B2Sep 5, 2006
Substituted amine derivatives and methods of use
AMGEN INC49 citations92
US9066954B2Jun 30, 2015
Fused heterocyclic derivatives and methods of use
AMGEN INC22 citations91
US7928140B2Apr 19, 2011
Benzothiazole PI3 kinase modulators for cancer treatment
AMGEN INC32 citations91
US7820665B2Oct 26, 2010
Imidazopyridazine inhibitors of PI3 kinase for cancer treatment
AMGEN INC38 citations91
US7652009B2Jan 26, 2010
Substituted heterocycles and methods of use
AMGEN INC33 citations91
US12083121B2Sep 10, 2024
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC7 citations85
US11993597B2May 28, 2024
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC8 citations85
US11905281B2Feb 20, 2024
KRAS G12C inhibitors and methods of using the same
AMGEN INC13 citations85
US11766436B2Sep 26, 2023
KRAS G12C inhibitors and methods of using the same
AMGEN INC11 citations85
US11285156B2Mar 29, 2022
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC16 citations85
US7759344B2Jul 20, 2010
Bis-aryl amide derivatives and methods of use
AMGEN INC15 citations84
US7687522B2Mar 30, 2010
Substituted pyridines and pyrimidines and their use in treatment of cancer
AMGEN INC8 citations83
US7101868B2Sep 5, 2006
Substituted arylamine derivatives and methods of use
AMGEN INC20 citations83
US8772480B2Jul 8, 2014
Inhibitors of PI3 kinase and/or mTOR
AMGEN INC5 citations71
US8017601B2Sep 13, 2011
Bis-aryl kinase inhibitors and method
AMGEN INC7 citations71
US12440491B2Oct 14, 2025
KRAS G12C inhibitors and methods of using the same
AMGEN INC1 citations64
US7915287B2Mar 29, 2011
Substituted heterocycles and methods of use
AMGEN INC4 citations62
US11845760B2Dec 19, 2023
PRMT5 inhibitors
AMGEN INC1 citations56
US7626030B2Dec 1, 2009
Compounds and methods of use
AMGEN INC1 citations52